Mutations play a critical role in influencing cancer treatment. Understanding the specific mutations present in a tumor can guide the choice of therapy. For example, tumors with mutations in the BRCA genes may respond well to PARP inhibitors. Similarly, tumors with specific mutations in the EGFR gene may be treated with EGFR inhibitors. Identifying mutations also helps in predicting treatment response and potential resistance mechanisms.
